IDERA PHARMACEUTICALS (NASDAQ: IDRA)





$4.68 0.02 (0.43%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
8.50
52-Week Low Price
4.48
Avg Volume (3 Mo.)
0.00 M
Market Cap
0.12 B
P/E Ratio (TTM)
97.6
Diluted EPS (TTM)
0.06
Shares
23.47 M
Dividend Rate ($) / (%)
0.00/0.00
0%
100%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -34% - IDRA has underperformed the S&P 500 by 60%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
OMEROS CORP (OMER) $5.69 -  $0.13(2.23%)0.13 B
AKORN INC (AKRX) $1.49 -  $0.13(9.56%)0.12 B
ONCOLYTICS BIOTECH INC (ONCY) $2.95 -  $0.33(12.60%)0.12 B
COMPUGEN LTD (CGEN) $4.39 -  $0.29(7.07%)0.12 B
ISTA PHARMACEUTICALS INC (ISTA) $3.74 -  $0.15(4.18%)0.12 B
LABOPHARM INC (DDSS) $1.91 -  $0.03(1.60%)0.12 B
GEOVAX LABS INC (GOVX) $0.14 -  $0.00(2.84%)0.11 B
INSMED INC (INSM) $0.80 -  $0.00(0.25%)0.11 B
PROLOR BIOTECH INC (PBTH) $3.10 -  $0.05(1.59%)0.11 B
REPLIGEN CORP (RGEN) $3.40 -  $0.05(1.49%)0.11 B
STOCK ANALYSIS
There are currently no Stock Analysis.
IDRA RELATED HEADLINES
arrow
StockPreacher.com Issues Trading Outlook for CEL-SCI Corp
StockPreacher.com Issues Trading Outlook for CEL-SCI Corp

by GlobeNewswire 9/22/2009
arrow
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors

At BusinessWire 11/20/2008
arrow
How to invest in biotech stocks
<ul> <li>Strategies for biotech investing</li> <li>Is biotech a secret revolution</li> <li>Latest CEO stock news</li> <ul>

Wall Street Media 11/10/2008
arrow
Idera Pharmaceuticals Reports Third Quarter 2008 Financial Results
Idera Pharmaceuticals Reports Third Quarter 2008 Financial Results

At BusinessWire 11/6/2008
arrow
Idera Pharmaceuticals to Present at Upcoming Investor Conferences
Idera Pharmaceuticals to Present at Upcoming Investor Conferences

At BusinessWire 10/27/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM2